Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Apply for the Fierce AI Innovation Awards - Submissions close Thursday, June 18
Poxel
Biotech
Perrigo CEO ousted over ‘personal conduct’—Chutes & Ladders
Perrigo CEO ousted over ‘personal conduct’. Apnimed transitions board chair to CEO. Poxel names CEO after debt default.
Zoey Becker
,
Will Maddox
Jun 12, 2026 8:30am
Poxel pivots to midphase rare metabolic disease programs
Jul 12, 2021 8:25am
Ahead of possible approval, Metavant backs off imeglimin
Nov 20, 2020 8:30am
Poxel gathers steam as NASH prospect cuts liver fat in phase 2
Oct 1, 2020 11:19am
Poxel posts phase 3 diabetes data ahead of approval decision
Sep 24, 2020 8:00am
Bayer, Poxel, Kymab and more—EuroBiotech Report
Apr 12, 2019 9:45am
